Description of Collaborative Activity: |
The National Institute of Allergy and Infectious Diseases (NIAID) and the Food and Drug Administration (FDA) collaborated on this workshop, which comprised 13 experts in the field of non-allergic rhinitis (NAR), representatives from seven stakeholder organizations, and National Institutes of Health (NIH) and FDA staff. The goal of this workshop was to better define NAR, clinical testing, phenotypes and pathophysiology for NAR, as well as to identify future clinical research opportunities and the potential for drug development. |
